The biomarker niche for fibroblast growth factor 23 testing in CKD.
Publication
, Journal Article
Wolf, M
Published in: J Am Soc Nephrol
January 2015
Duke Scholars
Published In
J Am Soc Nephrol
DOI
EISSN
1533-3450
Publication Date
January 2015
Volume
26
Issue
1
Start / End Page
7 / 9
Location
United States
Related Subject Headings
- Urology & Nephrology
- Male
- Kidney Diseases
- Humans
- Gene Expression Regulation
- Fibroblast Growth Factors
- Fibroblast Growth Factor-23
- Female
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wolf, M. (2015). The biomarker niche for fibroblast growth factor 23 testing in CKD. J Am Soc Nephrol, 26(1), 7–9. https://doi.org/10.1681/ASN.2014060621
Wolf, Myles. “The biomarker niche for fibroblast growth factor 23 testing in CKD.” J Am Soc Nephrol 26, no. 1 (January 2015): 7–9. https://doi.org/10.1681/ASN.2014060621.
Wolf M. The biomarker niche for fibroblast growth factor 23 testing in CKD. J Am Soc Nephrol. 2015 Jan;26(1):7–9.
Wolf, Myles. “The biomarker niche for fibroblast growth factor 23 testing in CKD.” J Am Soc Nephrol, vol. 26, no. 1, Jan. 2015, pp. 7–9. Pubmed, doi:10.1681/ASN.2014060621.
Wolf M. The biomarker niche for fibroblast growth factor 23 testing in CKD. J Am Soc Nephrol. 2015 Jan;26(1):7–9.
Published In
J Am Soc Nephrol
DOI
EISSN
1533-3450
Publication Date
January 2015
Volume
26
Issue
1
Start / End Page
7 / 9
Location
United States
Related Subject Headings
- Urology & Nephrology
- Male
- Kidney Diseases
- Humans
- Gene Expression Regulation
- Fibroblast Growth Factors
- Fibroblast Growth Factor-23
- Female
- 3202 Clinical sciences
- 1103 Clinical Sciences